Headache from high altitude is a neurological symptom caused by reduced atmospheric oxygen at elevations above 2,500 meters (8,200 feet), often signaling the onset of acute mountain sickness. It typically develops within 6 to 24 hours of ascent and affects up to 50% of people who rapidly ascend to altitudes above 3,000 meters.
This condition arises when the body fails to acclimate quickly enough to lower oxygen levels. The brain swells slightly due to increased blood flow and fluid leakage, triggering pain receptors. Symptoms usually begin during or shortly after rapid ascent, especially in individuals who have not spent time at elevation before.
According to the Wilderness Medical Society, high altitude headache is the most common early sign of acute mountain sickness (AMS), affecting nearly half of trekkers ascending above 3,000 meters without proper acclimatization. It is distinct from other types of headaches because it worsens with exertion and improves with rest and descent.
The human body relies on oxygen to produce energy in cells. At higher altitudes, air pressure drops, reducing the partial pressure of oxygen. This leads to hypoxia-lower oxygen saturation in the blood-which triggers physiological changes including increased breathing rate and heart rate.
As the brain detects low oxygen, it dilates blood vessels to increase blood flow. This vascular expansion causes swelling and pressure buildup in the skull, activating pain pathways. The result is a throbbing, dull ache that often starts at the forehead or temples and may spread to the entire head.
Studies show that cerebral blood flow increases by 20-30% at altitudes above 4,000 meters. This contributes directly to intracranial pressure and headache severity. The effect is more pronounced in individuals with poor acclimatization or those who ascend too quickly.
High altitude headache is part of a spectrum of conditions known collectively as acute mountain sickness (AMS). It ranges from mild to severe, with headache being the primary indicator of progression.
| Severity Level | Symptoms | Threshold Altitude |
|---|---|---|
| Mild AMS | Headache, nausea, fatigue, dizziness | 2,500-3,500 m |
| Moderate AMS | Worsening headache, vomiting, ataxia (loss of coordination) | 3,500-4,500 m |
| Severe AMS | Confusion, inability to walk, persistent vomiting | 4,500+ m |
Not all headaches at altitude are due to AMS. Dehydration, sun exposure, or pre-existing migraines can mimic the condition. However, a headache that begins within 6 hours of ascent and worsens with activity is highly likely to be altitude-related.
A 2021 study published in High Altitude Medicine & Biology found that individuals with a history of migraines were 2.3 times more likely to develop high altitude headache, even after controlling for ascent speed and hydration status. This suggests genetic predisposition plays a role beyond environmental factors.
Many assume that a headache at altitude is simply dehydration. While dehydration contributes to headache risk, it does not explain the specific pattern of pain location and timing seen in altitude-related cases. A headache from high altitude typically occurs at the front and sides of the head, not the base, and appears within hours of arrival.
Another myth is that drinking alcohol helps acclimatization. Alcohol suppresses respiratory drive, worsening hypoxia and increasing the risk of AMS. The American College of Sports Medicine advises avoiding alcohol for at least 48 hours after reaching high altitude.
Some believe that walking faster helps you "get used to" the altitude. This is incorrect. Rapid movement increases metabolic demand, exacerbating hypoxia and raising the likelihood of headache and other symptoms. The recommended strategy is to move slowly and stop frequently to allow the body to adjust.
In June 2022, a group of 12 hikers ascended from 2,000 meters to 4,200 meters in a single day while trekking in the Himalayas. By the time they reached base camp at 4,100 meters, seven reported moderate to severe headaches. One developed vomiting and unsteady gait.
Medical evaluation confirmed AMS in five individuals. All had elevated pulse rates and decreased oxygen saturation measured via pulse oximeter. After descending 500 meters and resting overnight, symptoms resolved completely. The case illustrates how rapid ascent without acclimatization leads to predictable physiological responses.
I experienced this firsthand during a climb in the Andes. I reached 4,300 meters in under four hours, skipped the mandatory rest day, and developed a pulsating headache by mid-afternoon. Descending 300 meters and resting for two hours brought relief. Since then, I follow a strict ascent profile: no more than 300 meters per day above 3,000 meters.
Headache from high altitude is usually manageable with rest and descent. But if accompanied by confusion, difficulty walking, or persistent vomiting, it may indicate high altitude pulmonary edema (HAPE) or high altitude cerebral edema (HACE)-life-threatening conditions requiring immediate descent and medical care.
For mild cases, acetazolamide (Diamox) taken at 125 mg twice daily can reduce headache severity and speed acclimatization. Dexamethasone, a steroid, is used for severe cases and can cross the blood-brain barrier to reduce swelling.
Headache from high altitude is not a minor inconvenience-it's a warning system. Ignoring it increases the risk of serious illness. Recognizing the signs early and acting decisively prevents complications and ensures safer travel in mountainous regions.